Missing n (%) | Patients with POH (N=53) | Patients without POH (N=352) | P Value | |
---|---|---|---|---|
SBP, mmHg | 0 | 111 (103 ~ 117) | 118 (110 ~ 127) | <0.001 |
DBP, mmHg | 0 | 64 (60 ~ 69) | 69 (62 ~ 75) | 0.001 |
HR, bpm | 0 | 71 (64 ~ 80) | 72 (67 ~ 79) | 0.806 |
NSVT | 0 | 8 (15.1) | 48 (13.6) | 0.774 |
Atrial Fibrillation | 0 | 4 (7.5) | 23 (6.5) | >0.999 |
LVOTPG at rest, mmHg | 0 | 79 (57 ~ 107) | 78 (48 ~ 107) | 0.396 |
LVOTPG provoking, mmHg | 6 (1.5) | 120 (82 ~ 154) | 125 (94 ~ 156) | 0.358 |
ABPR | 6 (1.5) | 13 (25) | 55 (15.9) | 0.102 |
LAVI, ml/m2 | 25 (1.5) | 48 (39 ~ 59) | 43 (36 ~ 54) | 0.051 |
EDVI, ml/m2 | 0 | 42 (37 ~ 49) | 45 (40 ~ 52) | 0.017 |
ESVI, ml/m2 | 0 | 16 (14 ~ 19) | 18 (15 ~ 21) | 0.010 |
SVI, ml/m2 | 0 | 25 (22 ~ 30) | 27 (24 ~ 31) | 0.070 |
EF, % | 0 | 59.7 (57.9 ~ 63.8) | 59.2 (57.0 ~ 62.5) | 0.040 |
IVSTmax, mm | 0 | 23 (21 ~ 29) | 24 (20 ~ 27) | 0.493 |
E/e’ | 10 (1.5) | 16.2 (12.9 ~ 21.5) | 16.0 (12.9 ~ 20.0) | 0.529 |
Moderate to Severe MR | 5 (6.2) | 31 (59.6) | 143 (41.1) | 0.012 |
Pericardial Effusion | 0 | 9 (17.0) | 37 (10.5) | 0.166 |
Pulmonary Hypertension | 0 | 8 (15.1) | 18 (5.1) | 0.006 |
Ventricular Aneurysm | 0 | 6 (11.3) | 11 (3.1) | 0.006 |
Sarcomere Mutations | 0 | 27 (50.9) | 129 (36.6) | 0.046 |
NT-proBNP, pg/ml | 0 | 1934 (905 ~ 2801) | 1125 (562.5 ~ 1917.5) | <0.001 |
RBC | 0 | 4.51 (4.23 ~ 4.79) | 4.88 (4.53 ~ 5.26) | <0.001 |
Hb, g/L | 0 | 134 (124 ~ 148) | 150 (138 ~ 161) | <0.001 |
HCT | 0 | 0.413 (0.382 ~ 0.434) | 0.448 (0.415 ~ 0.476) | <0.001 |
PLT | 0 | 187 (157 ~ 223) | 188 (155 ~ 225) | 0.735 |
Creatinine, per umol/L | 0 | 69 (59 ~84) | 71 (60 ~84) | 0.811 |
ePVS, ml/g | 0 | 4.40 (3.85 ~ 5.01) | 3.70 (3.23 ~ 4.26) | <0.001 |
Procedure Duration, min | 15 (3.7) | 72 (58 ~ 89) | 80 (60 ~ 104) | 0.013 |